Australian device regs
This article was originally published in The Gray Sheet
Comments on the 11July therapeutic goods draft document outlining Australia's medical devices regulations should be submitted by Aug. 12 to firstname.lastname@example.org. The updated draft includes material on conformity assessment procedures under the new Australian medical devices framework, based on principles set out by the Global Harmonization Task Force and expected to go into effect by Oct. 5...
You may also be interested in...
India has removed export restrictions on APIs and formulations imposed by the country in March. However, certain measures have been kept in place to ensure that domestic requirements are met for in-demand products such as hydroxychloroquine and paracetamol.
EU Approvals: Takeda advances its targeted ALK-positive NSCLC tyrosine kinase inhibitor into early lines of therapy, while Bayer and Finland’s Orion gain clearance for their androgen receptor inhibitor for prostate cancer.
The pharma giants are joining forces to help the UK reach its ambitious target of testing 100,000 people a day for coronavirus by the end of April.